Terms: = Lymphoma AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
328 results:
1. [Curcumin Combined with Thalidomide Inhibits Proliferation of KG-1 Cells and Its Related Mechanisms].
Liu J; Huang Y; Liu Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):422-427. PubMed ID: 38660846
[TBL] [Abstract] [Full Text] [Related]
2. Knockout of brca1-interacting factor Ola1 in female mice induces tumors with estrogen suppressible centrosome amplification.
Yoshino Y; Ogoh H; Iichi Y; Sasaki T; Yoshida T; Ichimura S; Nakayama M; Xi W; Fujita H; Kikuchi M; Fang Z; Li X; Abe T; Futakuchi M; Nakamura Y; Watanabe T; Chiba N
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167138. PubMed ID: 38537683
[TBL] [Abstract] [Full Text] [Related]
3. Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing.
Wang XN; Hong J; Xu YG; Zhang P; Li YY; Dou HL; Li HP
BMC Ophthalmol; 2024 Mar; 24(1):99. PubMed ID: 38438866
[TBL] [Abstract] [Full Text] [Related]
4. Breast cancer diagnosed after age 70 years in Israeli brca1/BRCA2 pathogenic sequence variant carriers: a single institution experience.
Bufman H; Faermann R; Halshtok-Neiman O; Shalmon A; Gotlieb M; Samoocha D; Yagil Y; Feldman DM; Friedman E; Sklair-Levy M
Breast Cancer Res Treat; 2024 Jun; 205(2):281-285. PubMed ID: 38379091
[TBL] [Abstract] [Full Text] [Related]
5. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma.
Mohsin N; Hunt D; Yan J; Jabbour AJ; Nghiem P; Choi J; Zhang Y; Freeman AF; Bergerson JRE; Dell'Orso S; Lachance K; Kulikauskas R; Collado L; Cao W; Lack J; Similuk M; Seifert BA; Ghosh R; Walkiewicz MA; Brownell I
JAMA Dermatol; 2024 Feb; 160(2):172-178. PubMed ID: 38170500
[TBL] [Abstract] [Full Text] [Related]
7. Role of non-chromosomal birth defects on the risk of developing childhood Hodgkin lymphoma: A Children's Oncology Group study.
Peckham-Gregory EC; Boff LM; Schraw JM; Spector LG; Linabery AM; Erhardt EB; Ribeiro KB; Allen CE; Scheurer ME; Lupo PJ
Pediatr Blood Cancer; 2024 Mar; 71(3):e30822. PubMed ID: 38146016
[TBL] [Abstract] [Full Text] [Related]
8. [
Xu HQ; Song LJ; Ding CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1690-1700. PubMed ID: 38071047
[TBL] [Abstract] [Full Text] [Related]
9. BRAT1-Associated Leukodystrophy Exacerbated by Classic Hodgkin lymphoma-Directed Therapy.
Hooshmand SJ; Chohan KL; Raghunathan A; Renaud DL; Ruff MW
Neurologist; 2024 May; 29(3):170-172. PubMed ID: 38019165
[TBL] [Abstract] [Full Text] [Related]
10. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
[TBL] [Abstract] [Full Text] [Related]
11. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
Tan XY; Tao J; Zhang Y; Gu RX
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
[TBL] [Abstract] [Full Text] [Related]
12. Expression of "DNA damage response" pathway genes in diffuse large B-cell lymphoma: The potential for exploiting synthetic lethality.
Mansoor A; Kamran H; Rizwan H; Akhter A; Roshan TM; Shabani-Rad MT; Bavi P; Stewart D
Hematol Oncol; 2024 Jan; 42(1):e3225. PubMed ID: 37795760
[TBL] [Abstract] [Full Text] [Related]
13. Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma.
Gong C; Wu J; Song W; Li H; Shi C; Gao Y; Shi Z; Li Z; Zhang M
Ann Hematol; 2023 Oct; 102(10):2845-2855. PubMed ID: 37500898
[TBL] [Abstract] [Full Text] [Related]
14. Pathology for severe inflammatory PML with PD1/PD-L1 expression of favorable prognosis: What's a prognostic factor for PML-iris?
Shishido-Hara Y; Akimoto J; Fukami S; Kohno M; Matsubayashi J; Nagao T
Neuropathology; 2024 Feb; 44(1):47-58. PubMed ID: 37424276
[TBL] [Abstract] [Full Text] [Related]
15. Preferred surgical techniques for secondary intraocular lens implantation in adults with aphakia.
Alshehri M; Bin Helayel H; Vargas JM; Almutlak M; Fairaq R
Int Ophthalmol; 2023 Oct; 43(10):3539-3547. PubMed ID: 37356032
[TBL] [Abstract] [Full Text] [Related]
16. The Implication of microRNAs as non-invasive biomarkers in 179 Egyptian breast cancer female patients.
Shaaban NZ; Ibrahim NK; Saada HN; El-Rashidy FH; Shaaban HM; Elbakary NM; Kodous AS
Oncol Res; 2022; 30(6):269-276. PubMed ID: 37303494
[TBL] [Abstract] [Full Text] [Related]
17. BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literature.
Carbonaro R; Accardo G; Mazzocconi L; Pileri S; Derenzini E; Veronesi P; Caldarella P; De Lorenzi F
Eur J Cancer Prev; 2023 Jul; 32(4):370-376. PubMed ID: 37302016
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of Inpatient Outcomes Between HIV Positive and Negative Hospitalizations for Autologous Stem Cell Transplant Treatment among Lymphoid Malignancies.
Ruiz M; Rubens M; Ramamoorthy V; Chavez CB; Saxena A
Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):e307-e313. PubMed ID: 37244799
[TBL] [Abstract] [Full Text] [Related]
19. Assessment of the Androgen Receptor in Older Women with Primary Breast Cancer: Association with a Panel of Biomarkers and Breast Cancer Specific Survival.
Kalvala J; Parks RM; Abdi J; Green AR; Cheung KL
Adv Ther; 2023 Jun; 40(6):2820-2835. PubMed ID: 37118159
[TBL] [Abstract] [Full Text] [Related]
20. Subcutaneous Microabscesses and Myositis as Part of Immune Reconstitution Inflammatory Syndrome due to Chronic Disseminated Candidiasis in a Child With Acute Lymphoblastic Leukemia.
Reddy NA; Addala S; S S S; Lashkari HP
J Pediatr Hematol Oncol; 2023 May; 45(4):e555-e559. PubMed ID: 37083275
[TBL] [Abstract] [Full Text] [Related]
[Next]
